Literature DB >> 12100815

Hydramnios: anomaly prevalence and sonographic detection.

Jodi S Dashe1, Donald D McIntire, Ronald M Ramus, Rigoberto Santos-Ramos, Diane M Twickler.   

Abstract

OBJECTIVE: To characterize the prevalence and ultrasound detection of fetal anomalies in pregnancies with hydramnios, and to estimate anomaly and aneuploidy risks when no sonographic abnormality is noted.
METHODS: This was a retrospective cohort study of singleton pregnancies with hydramnios. Hydramnios was categorized as mild, moderate, or severe based on greatest amniotic fluid index of 25.0-29.9 cm, 30.0-34.9 cm, or 35.0 cm or more, respectively. Antenatal anomaly detection was compared with assessment in the immediate neonatal period. Aneuploidy and fetal deaths were analyzed separately.
RESULTS: Hydramnios was diagnosed in 672 pregnancies, and 77 (11%) of neonates had one or more anomalies. Though more severe hydramnios was associated with higher likelihood of anomaly (P <.001), sonographic anomaly detection (79%) did not differ according to degree of hydramnios (P =.4). Of anomalies which eluded sonographic diagnosis, cardiac septal defects, cleft palate, imperforate anus, and tracheoesophageal fistula were the most frequent. If sonographic evaluation was normal, the risk of a major anomaly was 1% with mild hydramnios, 2% with moderate hydramnios, and 11% with severe hydramnios (P <.001). Aneuploidy was present in 10% of fetuses with sonographic anomalies and 1% without apparent sonographic anomalies. The fetal death rate was 4% in the setting of hydramnios; 60% of these cases had anomalies.
CONCLUSION: The anomaly detection rate in pregnancies with hydramnios was nearly 80%, irrespective of the degree of amniotic fluid increase. Residual anomaly risk after normal sonographic evaluation was 2% or less if hydramnios was mild or moderate and 11% if severe.

Entities:  

Mesh:

Year:  2002        PMID: 12100815     DOI: 10.1016/s0029-7844(02)02013-6

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  12 in total

Review 1.  Indications for fetal echocardiography.

Authors:  M Small; J A Copel
Journal:  Pediatr Cardiol       Date:  2004 May-Jun       Impact factor: 1.655

2.  Perinatal Outcome in Idiopathic Polyhydramnios.

Authors:  Meenakshi Lallar; Rajesh Nandal
Journal:  J Obstet Gynaecol India       Date:  2014-10-29

Review 3.  Reducing stillbirths: screening and monitoring during pregnancy and labour.

Authors:  Rachel A Haws; Mohammad Yawar Yakoob; Tanya Soomro; Esme V Menezes; Gary L Darmstadt; Zulfiqar A Bhutta
Journal:  BMC Pregnancy Childbirth       Date:  2009-05-07       Impact factor: 3.007

4.  The effect of polyhydramnios degree on chromosomal microarray results: a retrospective cohort analysis of 742 singleton pregnancies.

Authors:  Lena Sagi-Dain; Amihood Singer; Tzipora Falik-Zaccai; Amir Peleg; Anat Bar-Shira; Michal Feingold-Zadok; Shay Ben Shachar; Idit Maya
Journal:  Arch Gynecol Obstet       Date:  2021-02-16       Impact factor: 2.344

5.  Polyhydramnios: Causes, Diagnosis and Therapy.

Authors:  A Hamza; D Herr; E F Solomayer; G Meyberg-Solomayer
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-12       Impact factor: 2.915

6.  Polyhydramnios as a predictor of adverse pregnancy outcomes.

Authors:  Kaukab Tashfeen; Ilham Moosa Hamdi
Journal:  Sultan Qaboos Univ Med J       Date:  2013-02-27

7.  Amniotic fluid deficiency and congenital abnormalities both influence fluctuating asymmetry in developing limbs of human deceased fetuses.

Authors:  Clara Mariquita Antoinette ten Broek; Jessica Bots; Irma Varela-Lasheras; Marianna Bugiani; Frietson Galis; Stefan Van Dongen
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240

8.  Effectiveness of fetal ultrasound diagnostics in cardiac malformations and association with polyhydramnios and oligohydramnios.

Authors:  Atene Simonyi; Fanni Rebeka Eros; Julia Hajdu; Artur Beke
Journal:  Quant Imaging Med Surg       Date:  2021-07

9.  Polyhydramnios and cerebellar atrophy: a prenatal presentation of mitochondrial encephalomyopathy caused by mutations in the FBXL4 gene.

Authors:  Maartje C van Rij; Fenna A R Jansen; Debby M E I Hellebrekers; W Onkenhout; Hubert J M Smeets; Alexandra T Hendrickx; Ralph W H Gottschalk; Sylke J Steggerda; Cacha M P C D Peeters-Scholte; Monique C Haak; Yvonne Hilhorst-Hofstee
Journal:  Clin Case Rep       Date:  2016-03-16

10.  Treatment and Outcome for Children with Esophageal Atresia from a Gender Perspective.

Authors:  Julia Ekselius; Martin Salö; Einar Arnbjörnsson; Pernilla Stenström
Journal:  Surg Res Pract       Date:  2017-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.